Astra Aktiebolag

Aktiebolaget Astra

Alan John Cross

Duncan Alastair Gray

Richard Alfred Green

Robin Bernad Boar

Bernard R Boar

Alfred R Green

Curt-Eric Hagberg

Heterocyclic compounds and compositions having nevropharmacological

(1-Heteroazolyl-1-heterocycane derivatives and their use as

(1-phenyl-1-heterocyclyl)methanol and (1-phenyl-1-heterocyclyl

The present invention relates to novel heterocyclic compounds having the general formula (1) ##STR1## geometric and optical isomers and racemates thereof where such isomers exist, as well as pharmaceutically acceptable acid addition salts thereof and solvates thereof; having therapeutic activity, processes and intermediates for their preparation, pharmaceutical formulations containing said compounds and the medicinal use of said compounds.

1-heteroazolyl-1-heterocyclyl alkane derivatives and their use and their

The present invention relates to an oxindole compound having the formula 5-cyclohexyl-1,3-dihydro-1-[2-[4-(phenylmethyl)-1-piperazinyl]ethyl]-2H-in dol-2-one for the prevention or treatment of cognitive dysfunctions.

Composition containing an oxoindole compound

A thiazole of the following formula is disclosed ##STR1## for the treatment of neurodegeneration involving loss of neuronal structure.

Chlormethiazole in the treatment of neurodegeneration

New pharmaceutical formulations comprising 5-(2-chloro-1-hydroxyethyl)-4-methylthiazole or optical isomers or a pharmaceutically acceptable salt or solvate thereof.

Pharmaceutical formulations

Growing community of inventors

Surrey, United Kingdom

Alan John Cross